Substituted fused heteroaryl compound serving as kinase inhibitor, and applications thereof
CN110167941AActive Publication Date: 2019-08-23IMPACT THERAPEUTICS (SHANGHAI) INC
5 Cites 3 Cited by
Patent Information
- Application Number
- CN201880006343.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2017-01-09
- Filing Date
- 2018-01-09
- Publication Date
- 2019-08-23
- Estimated Expiration
- 2038-01-09
Abstract
The present invention provides a substituted fused heteroaryl compound serving as a kinase inhibitor, and applications thereof. Specifically, the present invention provides a compound represented by formula I, or a medicinal salt or a prodrug thereof, A1-A4, B1-B3, D1-D4 and R1-R3 being defined herein. The compound represented by formula I is a kinase inhibitor. Accordingly, the compound in the present invention can be used for treating cancer and other clinical conditions caused by a defect in a DDR function.
Need to check novelty before this filing date? Find Prior Art